FindTrial
Sign In

Diagnostic Performance of CT-derived resting Pd/Pa vs CT-derived FFR in Coronary Lesion Severity Assessment

Diagnostic Performance of CT-derived resting Pd/Pa vs CT-derived FFR in Coronary Lesion Severity Assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034345
Enrollment
Unknown
Registered
2020-07-02
Start date
2020-04-15
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Gold Standard:CT-derived resting Pd/Pa (CT-(Pd/Pa)rest)
Index test:invasive&#32
resting&#32
Pd/Pa&#32
and&#32
CT-FFR&#32
with&#32
invasive&#32
FFR

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients who underwent coronary CTA by 64-row CT scanners or above, along with invasive coronary angiography (ICA), and FFR measurements within the next 30 days afterwards

Exclusion criteria

Exclusion criteria: 1) major interprocedural adverse cardiac events (myocardial infarction, cardiac death, or revascularization); 2) complicated congenital heart diseases; 3) previous coronary artery bypass surgery or stenting; 4) installed pacemaker; 5) artificial heart valves; 6) bifurcation stenosis; 7) chronic total occlusion; 8) non-diagnostic quality of CTA data 9) body mass index (BMI)>=35; 10) prior myocardial infarction; 11) unqualified pressure curve for resting Pd/Pa or FFR analysis.

Design outcomes

Primary

MeasureTime frame
CT-FFR;Kappa;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactYong Zeng

Beijing Anzhen Hospital, Capital Medical University

13501373114@163.com+86 13501373114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026